Hastane Personelinde Fekal Vankomisin Dirençli Enterokok Kolonizasyonunun Arastirilmasi

Bu çalismada, Düzce Tip Fakültesinde hastane personelinde fekal vankomisin dirençli enterokok (VRE) kolonizasyonu arastirilmistir. Diski kültürlerinden enterokok izole edilen 62 hastane personeli ve 37 gönüllü bu çalismaya alindi. Diski örneklerinden enterokok kökenlerinin identifikasyonunda klasik mikrobiyolojik yöntemler ve API 20 Strep testi kullanildi. Antimikrobiyal duyarlilik testleri disk difüzyon yöntemiyle yapildi. Betalaktamaz aktivitesi nitrosefin diskleriyle çalisildi. Izole edilen toplam enterokok kökenlerinin türlere göre dagilimi: 56 (%56.6) E.faecium, 24 (%24.2) E.gallinarum, 13 (%13.1) E.faecalis, 5 (%5.1) E.durans, 1 (%1.0) E.casseliflavus olarak belirlenmistir. Hastane personelinden izole edilen tüm enterokok kökenleri arasinda ampisilin direnci %12.9, Yüksek düzey streptomisin (YDS) direnci %19.4 ve Yüksek düzey gentamisin (YDG) direnci %1.6 olarak saptanmistir. YDS direnci hastane personelinde kontrol grubuna göre anlamli sekilde yüksek bulundu (x2:8.149, p=0.002). Hiçbir enterokok susunda vankomisin direnci ve betalaktamaz aktivitesi saptanma mistir. Sonuç olarak, hastane personelinde fekal VRE tasiyiciligi saptanmadi. Ancak periyodik tarama çalismalarinin sürdürülmesinin dirençli kökenlerin erken saptanmasi açisindan gerekli olduguna inaniyoruz

The Investigation Of Fecal Vancomycin Resistant Enterococcus Colonization In Hospital Personnel

In this study, the prevalence of fecal vancomycin resistant enterococcus (VRE) colonization was investigated in hospital personnel in Duzce Medical Faculty. Sixty two hospital personnel and 37 volunteer whom enterococcus species had isolated from stool samples were included in the study. The classical microbiological methods and API 20 Strep was used for the identification of enterococcus species from stool samples. Susceptibility was determined by the disk diffusion method. The beta lactamase activitywas tested with nitrocephin disk. According to our results 56 (56.6%) of the isolated enterococcus species was identified as E.faecium, 24 (24.2) % as E.gallinarum, 13 (13.1%) as E.faecalis, 5 (%5.1) as E.durans, and 1 (%1.0) E.casseliflavus. Resistance to ampicillin was found in 12.9% of samples. High-level resistance to gentamicin was found in 9.9% of samples. 19.8% of samples were found to be highly resistant to streptomycin. High-level resistance to streptomycin was higher in hospital personnel than control group (x2:8.149, p=0.002). No vancomycin resistance was noted. It was found that none of the enterococci had beta-lactamase enzyme activity. Our results demonstrated that there is no fecal carriage of VRE in hospital personnel. However we suggest that the screening tests should be done periodically to reveal resistant strains early

___

  • Yüce A, Karaman M, Gülay Z, Yulug N. Yenidoganlarda vankomisin dirençli enterokoklarin fekal tasiyic iligi. ANKEM Derg. 13:7-l 1, 1999.
  • Moellering RC, JR. Enterococcus species, Streptococcus bovis and leuconostoc species. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases. Sixth edition. New York. Churchill Livingstone. 2411-2421, 2005.
  • Teixeira LA, Facklam RR. Enterococcus. In: Murray PR, Baron EJ. Pfaller MA, Tenover FC, Yolken RH (eds). Manual of Clinical Microbiology. Eighth edition, Washington: ASM Pres.422-433, 2003.
  • Antimikrobik Duyarlilik Testleri için Uygulama Standartlari; Onbesinci Bilgi Eki. CLSI dökümani M100-S15. CLSI, Ankara: TMC Yayini, 2005.
  • Baran JJr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vanco- mycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol. 23:23-6, 2002.
  • Carmali Y, Venkataraman L, DeGirolami PC, Lichtenberg DA, Karchmer AW, Samore MH. Stool colonization of healthcare workers with selected resistant bacteria. Infect Control Hosp Epidemiol. 19:38-40, 1998.
  • Bonten MJM, Hayden MK, Nathan C, Voorhis JV, Matushek M, Slaughter S, Rice T, Weinstein RA. Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet. 348:1615-19,1996.
  • Rubin LG, Tucci V, Cercenado E, Eliopoulus G, Isenberg HD. Vancomycin- resistant hospitalized children. Infect Control Hosp Epidemiol.13:700-5, 1992.
  • Handwerger S, Raucher B, Altarac D, Monka J, Marchione S, Singh KV, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicilin, and gentamicin. Clin Infect Dis.16:750-5, 1993.
  • Wend C, Krause C, Xander LU, Loffler D, Floss H. Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany. J Hosp Infect. 42: 193-200, 1999.
  • Coque TM, Arduino RC, Murray BE. High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clin Infect Dis.20(4): 1048-51, 1995.
  • Çaylan R, Üstünakin M, Kadimov V, Aydin K, Koksal I. Fekal ve klinik örneklerden izole edilen enterokok suslarinin antibiyotiklere duyarliliklari. Türk Mikrobiyol Cem Derg.34; 24-28, 2004.
  • Kuzucu C, Cizmeci Z, Durmaz R, Durmaz B, Ozerol IH. The prevalence of fecal colonization of enterococci, the resistance of the isolates to ampicillin, vancomycin, and high-level aminoglycosides, and the clonal relationship among isolates. Microb Drug Resist. Summer. 11(2):159-64, 2005.
  • Boost M, Lai L, O'Donoghue M. Drug resistance in fecal enterococci in Hong Kong. J Infect Chemother. 10(6): 326-30, 2004.
  • Eskitürk A, Ekti M, Çulha G, Korten V. Hastanede yatan hastalarda ve kanalizasyon örneklerinde vankomisin ve yüksek düzey aminoglikozid dirençli enterokok Mikrobiyoloji Bülteni. 31(3): 219-229, 1997. arastirilmasi A, Simonsen GS, Sundsfjord A. The prevalence of faecal carriage of ampicillin- resistant and high-level gentamicin- resistant enterococci among inpatients at 10 major Norwegian hospitals. J Hosp Infect. 50(2) :145-54, 2002.
  • Rhinehart E, Smith NE, Wennersten C, Freenman J, Eliopoulos GM, Moellering RC, et al. Rapid dissemination of β- lactamase-producing, aminoglycoside- resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 323: 1814-7, 1990.
  • Tan B, Berkem R, Acar N. Hastanede yatan hastalarda ampisilin ve vankomisine dirençli enterokok kolonizasyonunun arastirilmasi. Mikrobiyoloji Bült. 35(3): 367-375, 2001.
  • Gordon S, Swenson JM, Hill BC, Pigott NE, Facklam RR, Cooksey RC, Thornberry C, Enterococcal Study Group, Jarvis WR, Tenover FC. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol.30:2373-2378, 1992.
  • Coudron PE, Markowitz 5M, Wong ES. Isolation of a aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother. 36:1125-1126, 1992.
  • Gökahmetoglu S, Sümerkan B, Esel D, Karagöz S. Kan kültürlerinden izole edilen enterokok suslarinin vankomisin ve yüksek düzey aminoglikozid dirençlerinin arastirilmasi. ANKEM Derg. 13: 57-62, 1999.
  • Çinar T, Leblebicioglu H, Sünbül M, Eroglu C, Esen S, Günaydin M. Enterokoklarda yüksek düzey gentamisin ve streptomisin direncinin arastirilmasi. Flora. 4:114-119, 1999.
  • Öztürk R, Eroglu C, Köksal F, Mert A, Aygün G. Enterokoklarda antibiyotiklere direnç ve yüksek düzeyde gentamisin direnci. ANKEM Derg. 9:351-354, 1995. 8